• KOL
    • KOLs Community
    • Plasma
    • Plasma Cells
    • Peter Roger Morgan
    • Peter Roger Morgan

      Peter Roger Morgan

      Head and Neck Pathology, King’s College London, Guy’s Hospital, London SE1 9RT, UK;, peter.morgan@kcl.ac.uk | Head & Neck Pathology, King's College London, Guy's Hospital, ...

       

       

      KOL Resume for Peter Roger Morgan

      Year
      2022

      Head and Neck Pathology, King’s College London, Guy’s Hospital, London SE1 9RT, UK;,

      2021

      Head & Neck Pathology, King's College London, Guy's Hospital, London, UK

      2020

      Head and Neck Pathology, Guy's and St Thomas's NHS Foundation Trust

      King’s College London, UK

      2018

      Department of Mucosal and Salivary Biology, King’s College London, Guy’s Hospital, Great Maze Pond, SE1 9RT, London, UK

      2016

      Department of Pathology, King's College London, London, UK.

      2015

      Head and Neck Pathology, Dental Institute, King’s College London, London, UK

      2014

      Head and Neck/Oral Pathology, Dental Institute, King’s College London, London, UK

      2013

      Authors' Affiliations: Clinical and Diagnostic Sciences, King's College London; Oral Pathology, Guy's and St Thomas' NHS Foundation Trust, Floor 28 Tower Wing, Guy's Hospital; Thames Cancer Registry, Division of Cancer Studies, King's College London; Oral Medicine; and WHO Collaborating Centre for Oral Cancer and Precancer UK, King's College London Dental Institute, Bessemer Road, London, United Kingdom

      2012

      Oral Pathology, King’s College London Dental Institute, London, UK

      2011

      Department of Oral Pathology, King's College London & Guy's and St Thomas' Hospital NHS Foundation Trust, Great Maze Pond, London. SE1 9RT. UK

      2009

      Professor, Department of Oral Pathology, GKT Dental Institute, Guy's Tower, King's College London, Guy's Hospital, London, UK

      2008

      Department of Head & Neck Oncology, Guy's, King's & St Thomas’ Cancer Centre, Guy's & St Thomas’ NHS Foundation Trust, 3rd Floor, Thomas Guy House, London SE1 9RT, UK

      2007

      Haartman Institute, Department of Pathology, FIN-00014 University of Helsinki, Finland;

      Department of Oral Pathology, King’s College London, Guy’s Hospital, London SE1 9RT, United Kingdom

      2006

      Department of Oral Pathology, King’s College London Dental Institute, Floor 28 Guy’s Tower, Guy’s Hospital, London SE1 9RT, UK

      2005

      Professor, Department of Oral Pathology, GKT Dental Institute, Guy's Tower, King's College London, Guy's Hospital, London

      2004

      Department of Oral Pathology, Guy's Hospital, London, SE1 9RT, UK

      2003

      Department of Oral Medicine and Pathology, Guy's, King's and St Thomas' Dental Institute, Guy's Hospital, London, UK;

      2001

      Department of Oral Medicine & Pathology, Guy's, King's and St. Thomas' Dental Institute, Guy's Hospital, London SE1 9RT, UK

      2000

      Department of Oral Medicine and Pathology, Guy’s, King’s and St. Thomas’ Dental Institute, Guy’s Hospital, London Bridge, UK

      1999

      THE GUY’S, KING’S COLLEGE AND ST THOMAS’ HOSPITALS, aResearch Fellow, Department of Oral Medicine and Pathology, Medical and Dental School, bResearch Student, Department of Oral Medicine and Pathology, Medical and Dental School, cSenior Lecturer, Hon Consultant, Department of Oral Medicine and Pathology, Medical and Dental School, dReader, Hon Consultant, Department of Oral Medicine and Pathology, Medical and Dental School

      London, United Kingdom

      1997

      Department of Oral Medicine and Pathology, UMDS Guy's Hospital,

      1996

      Department of Oral Medicine and Pathology, United Medical and Dental School of Guy's and St. Thomas' Hospitals, London, UK

      1995

      Department of Oral Medicine & Pathology, UMDS, Floor 28, Guy's Tower, Guy's Hospital, London SE1 9RT, UK

      Guy's and St. Thomas' Hospitals Trust, London, U.K.

      1994

      Department of Oral Medicine and Pathology, UMDS, Floor 28, Guy's Tower, Guy's Hospital, London SE1 9RT, U.K.

      1993

      Departments of Oral Medicine & Pathology, UMDS, London

      1992

      Department of Oral Medicine and Pathology, UMDS (Guy’s Campus), London, England

      1991

      Department of Oral Medicine and Pathology, United Medical and Dental Schools, Guy's Hospital, London, U. K

       

       

      Peter Roger Morgan: Influence Statistics

      Sample of concepts for which Peter Roger Morgan is among the top experts in the world.
      Concept World rank
      sporadic kcot #1
      k13 k1 #1
      diagnostic relevance emphasis #1
      complex management area #1
      k18 differentiationlinked keratins #1
      keratins normal #1
      emphasis common lesions #1
      ameloblastoma uam #1
      enhanced k1 #1
      scc keratin #1
      keratins oral #1
      findings benign cysts #1
      occasional k7 #1
      k10 differentiated #1
      k4 k13 complex #1
      grading parameters #1
      filaments oral #1
      differentiationlinked keratins #1
      epithelia k14 #1
      factors ameloblastoma #1
      biological applied #1
      k10 oral #1
      k4 k13 #1
      k14 transcript #2
      nok svpgc2a #2
      keratins organotypic culture #2
      level ck19 #2
      k14 mrna #2
      k18 k18 mrnas #2
      k8 k18 mrnas #2
      keratin mrnas #2
      variable expression mrna #2
      keratins svpgc2a #2
      cytokeratin messenger #2
      proteins k7 #2
      cornified sites #2
      k18 k7 k8 #2
      normal epithelia k14 #2
      case metastasizing pleomorphic #2
      moderate severe dysplasias #2
      expression keratin mrnas #2
      chemiluminescence tblue #2
      svpgc2a cell #2

       

      Prominent publications by Peter Roger Morgan

      KOL-Index: 12053

      The chemokines (CKs) CXCL13, CCL21, and CXCL12 are known to play differential roles in the organization of the lymphoid tissues and the development of lymphoid malignancies. We investigated the expression of these CKs and their receptors in the salivary glands of Sjogren's syndrome patients with lymphoepithelial lesions (lymphoepithelial sialadenitis or LESA) and in MALT lymphoma to understand their involvement in salivary gland lymphomagenesis. We demonstrate that within salivary glands ...

      Known for Salivary Glands | Malt Lymphoma | Epithelial Cells | Chemokine Cxcl12 | Sjögren Syndrome
      KOL-Index: 11381

      Demonstration of ectopic germinal center-like structures (GC-LSs) in chronically inflamed tissues in patients with autoimmune disorders is a relatively common finding. However, to what extent ectopic lymphoid structures behave as true GC and are able to support class switch recombination (CSR) and somatic hypermutation (SHM) of the Ig genes is still debated. In addition, no information is available on whether CSR and SHM can take place in the absence of GCs at extrafollicular sites in an ...

      Known for Malt Lymphoma | Autoimmune Sialoadenitis | Cytidine Deaminase | Follicular Dendritic | Ectopic Lymphoid Structures
      KOL-Index: 10172

      Immunologically, the parotid salivary gland is an effector site that secretes large quantities of polyspecific Abs into the saliva, mainly of the IgA isotype. It is considered to be part of the common mucosal immune system but the inductive site for the Ab-producing cells of the salivary gland has not yet been clearly identified. The origin and diversity of cells of B lineage can be investigated by analyzing their Ig heavy chain genes (IgH). We have obtained sequences of IgM and IgA ...

      Known for Plasma Cells | Salivary Gland | Igm Genes | Immunoglobulin Humans | Human Iga
      KOL-Index: 10044

      Mucous membrane pemphigoid (MMP) is an autoimmune blistering disease frequently associated with scarring of involved clinical sites. At present, therapeutic intervention in the form of immunomodulating or immunosuppressive agents is often reserved until the onset of significant inflammation and/or early cicatrization. We have therefore studied the clinical and immunopathological findings in 67 patients with MMP in order to try to establish a reliable prognostic indicator by which ...

      Known for Patients Igg | Membrane Pemphigoid | Clinical Score | Antibody Response | Indirect Immunofluorescence
      KOL-Index: 9870

      Keratins have been extensively studied in tissues and cultured keratinocytes but limited information is available on epithelia reconstructed in vitro. The aim of this study was to examine keratin expression in organotypic epithelia with normal (NOK), immortalized (SVpgC2a) and malignant (SqCC/Y1) human buccal cells. Organotypic epithelia were derived from 10 days of culture at the air-liquid interface of collagen gels containing human oral fibroblasts using a standardized serum-free ...

      Known for Organotypic Culture | Keratins Svpgc2a | Keratin Expression | Sqcc Y1 | Mucosa Mouth
      KOL-Index: 9621

      BACKGROUND:  Oral potentially malignant disorders (OPMD) are known to precede the development of oral cancer. Detection of OPMD allows delivery of interventions that may reduce the evolution of these disorders to malignancy. Following oral examinations, the accuracy of detection of OPMD by chemiluminescence was evaluated using a commercially available detection kit - ViziLite. Data derived were compared in relation to conventional oral examination and surgical biopsy.

      METHODS: A total of ...

      Known for Oral Lichen Planus | Malignant Disorders | Detection Opmd | Surgical Biopsy | Tests Sensitivity
      KOL-Index: 9456

      BACKGROUND: The histologic grading of the deep invasive margin of oral squamous cell carcinoma recently has been shown to have prognostic value, but previous series have not been homogeneous enough to allow grading parameters to be assessed individually.

      METHODS: Forty-seven small lingual carcinomas limited to the lateral border of the tongue and treated by radiotherapy were graded histologically at their deep invasive front. Clinical and grading parameters were correlated by statistical ...

      Known for Cell Carcinoma | Pattern Invasion | Histologic Grading | Deep Invasive | Lateral Border
      KOL-Index: 9358

      This study was undertaken to analyze keratin gene expression at both the mRNA and protein level in oral hairy leukoplakia (OHL). Comparisons were made with normal lingual epithelium from a similar site, tongue biting, normal buccal mucosa and another condition which disturbs oral epithelial differentiation, white sponge nevus. Combined immunocytochemical and in situ hybridization studies for keratins 14 and 19 were carried out on 2 specimens of OHL from HIV-positive males and one sample ...

      Known for Hairy Leukoplakia | Sponge Nevus | Oral Epithelia | Basal Cells | Expression Keratin
      KOL-Index: 9258

      Control of keratin (K) gene expression may be important for cell differentiation in complex epithelia such as salivary gland. To investigate differences in distribution between keratin mRNAs and their respective proteins, a combined in situ hybridization (ISH) and immunohistochemical study was undertaken on nine normal salivary glands and seven pleomorphic adenomas. ISH employed riboprobes to K7, K8, K14, K18, and K19. Immunohistochemistry was performed on adjacent sections using ...

      Known for Pleomorphic Adenomas | K7 K8 | K14 Mrna | Neoplastic Humans | Salivary Gland
      KOL-Index: 8944

      Dysplasia grading is widely used to assess risk of transformation in oral potentially malignant disorders despite limited data on predictive value. DNA ploidy analysis has been proposed as an alternative. This study examines the prognostic value for both tests used in a routine diagnostic setting to inform clinical management. A retrospective study of conventional dysplasia grading was conducted on 1,401 patients. DNA ploidy analysis was conducted on a subset of 273 patients and results ...

      Known for Dysplasia Grading | Dna Ploidy | Malignant Transformation | Risk Lesions | Retrospective Studies
      KOL-Index: 8916

      Ten lesions from eight cases are presented of a rare intra-osseous jaw lesion with the combined histological features of giant cell granuloma and central odontogenic fibroma. Lesions arose over a wide age range and presented as monolocular or multilocular radiolucencies with cortical expansion and, in one case, perforation. Two lesions recurred after curettage, one being eradicated by a second curettage and one by conservative excision. Histologically, zones of typical giant cell ...

      Known for Giant Cell | Central Odontogenic Fibroma | Recurrence Curettage | Odontogenic Tumors | Jaw Neoplasms
      KOL-Index: 8877

      Early detection of oral cancer is crucial in improving survival rate. Identification and detection of oral potentially malignant disorders (OPMD) allow delivery of interventions to reduce the evolution of these disorders to malignancy. A variety of new and emerging diagnostic aids and adjunctive techniques are currently available to potentially assist in the detection of OPMD. The objective of the present study was to evaluate the accuracy of autofluorescence against conventional oral ...

      Known for Malignant Disorders | Detection Oral | Specificity Velscope | 126 Patients | Surgical Biopsy
      KOL-Index: 8356

      Ameloblastoma is a benign but locally infiltrative odontogenic neoplasm. Although ameloblastomas rarely metastasise, recurrences together with radical surgery often result in facial deformity and significant morbidity. Development of non-invasive therapies has been precluded by a lack of understanding of the molecular background of ameloblastoma pathogenesis. When addressing the role of ERBB receptors as potential new targets for ameloblastoma, we discovered significant EGFR ...

      Known for Braf V600e | Tumor Cell | Sanger Sequencing | Erbb Receptors | Facial Deformity
      KOL-Index: 8273

      BACKGROUND:  The value of chairside adjunctive tests in the detection of oral potentially malignant disorders (OPMDs) remains uncertain.

      OBJECTIVES:  To determine the effectiveness of toluidine blue in detecting leukoplakia and erythroplakia and its accuracy in identifying cases with oral epithelial dysplasia.

      MATERIALS AND METHODS:  Ninety-two patients attending two oral medicine clinics in London, presenting with white and red patches of the oral mucosa, were investigated by the ...

      Known for Toluidine Blue | Malignant Disorders | Oral Cavity | Surgical Biopsy | Histological Assessment

      Key People For Plasma Cells

      Top KOLs in the world
      #1
      Aandreas Radbruch
      plasma cells bone marrow systemic lupus erythematosus
      #2
      Robert A Kyle
      multiple myeloma undetermined significance consultancy funding
      #3
      Kenneth Carl Anderson
      multiple myeloma mm cells board directors
      #4
      David Mathew Tarlinton
      plasma cells germinal center bone marrow
      #5
      Rudolf Armin Manz
      plasma cells bone marrow bullosa acquisita
      #6
      Thomas Ernst Dörner
      rheumatoid arthritis systemic lupus erythematosus plasma cells

      Peter Roger Morgan:Expert Impact

      Concepts for whichPeter Roger Morganhas direct influence:Plasma cells,  Dna ploidy,  Oral lichen planus,  Salivary gland,  Malt lymphoma,  Toluidine blue,  Keratin expression,  Squamous cell.

      Peter Roger Morgan:KOL impact

      Concepts related to the work of other authors for whichfor which Peter Roger Morgan has influence:Oral cancer,  Squamous cell,  Malignant transformation,  Salivary glands,  Odontogenic tumors,  Mucous membrane,  Lichen planus.


       

      Tools

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile


      Head and Neck Pathology, King’s College London, Guy’s Hospital, London SE1 9RT, UK;, peter.morgan@kcl.ac.uk | Head & Neck Pathology, King's College London, Guy's Hospital, London, UK | Head & Neck Pathology, Guy's and St Thomas' NHS Foundation Trust,

    Download on the App StoreGet it on Google Play

    Copyright © 2023 - KOL means Key Opinion Leaders .

    KOL does not provide medical advice, diagnosis or treatment.